Abstract
A 9-year-old boy with Down's syndrome developed a glomerulonephritis associated with crescents and anti-neutrophil cytoplasmic antibodies (ANCA). The patient also had type 1 diabetes mellitus, chronic lymphocytic thyroiditis, and bronchial asthma. Prednisone therapy resulted in an improvement in renal function and a reduction in ANCA titers.
References
Ariel I, Wells TR, Landing BH, Singer DB (1991) The urinary system in Down syndrome: a study of 124 autopsy cases. Pediatr Pathol 11: 879–888
Gupta SK, Venkataseshan VS, Churg J (1991) Mesangiocapillary glomerulonephritis in Down's syndrome. Am J Nephrol 11: 112–117
Takemura T, Yoshioka K, Akano N, Michihata I, Okada M, Maki S, Shigematsu H (1993) Immunotactoid glomerulopathy in a child with Down syndrome. Pediatr Nephrol 7: 86–88
Woodman RC, Ruedi JM, Jesairis AJ, Okamura N, Quinn MT, Smith RM, Curnutte JT, Babior BM (1991) Respiratory burst exidase and three of four oxidase-related polypetides are associated with the cytoskeleton of human neutrophils. J Clin Invest 87: 1345–1351
Dillon MJ, Tizard EJ (1991) Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies. Pediatr Nephrol 5:256–259
Nash MC, Jones CL, Walker RG, Powell HR, (1993) Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in children. Pediatr Nephrol 7: 11–14
Walters MDS, Savage COS, Dillon MJ, Lockwood CM, Barratt TM (1988) Anti-neutrophil cytoplasm antibody in crescentic glomerulonephritis. Arch Dis Child 63: 814–817
Hagen EC, Ballieux B, Es LA van, Daha MR, Woude FJ van der (1993) Anti-neutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81: 1996–2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robson, W.L.M., Leung, A.K.C., Woodman, R.C. et al. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis in a patient with Down's syndrome. Pediatr Nephrol 9, 204–205 (1995). https://doi.org/10.1007/BF00860750
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00860750